TITLE

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease

AUTHOR(S)
Karalis, Dean G.
PUB. DATE
April 2009
SOURCE
Mayo Clinic Proceedings;Apr2009, Vol. 84 Issue 4, p345
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Coronary artery disease (CAD) is the leading cause of morbidity and mortality in the United States, and a high concentration of low-density lipoprotein cholesterol (LDL-C) Is a major risk factor for CAD. Current guidelines recommend the use of statins to lower LDL-C levels for the primary prevention of CAD based on an individual's risk factor profile and baseline LDL-C level. For moderaterisk individuals, those with 2 or more major risk factors for CAD and a Framingham risk score of 10% to 20%, the recommendation is to use a statin to lower LDL-C levels to less than 130 mg/dL. However, up to 40% of individuals who develop CAD have LDL-C levels lower than this cutoff. in 2004, the National Cholesterol Education Program Adult Treatment Panel Ill guidelines were updated to include an LDL-C goal of less than 100 mg/dL for Individuals at moderately high risk of developing CAD. The guidelines identified several risk factors that when present would favor the use of pharmacological therapy to achieve this more aggressive LDL-C goal. This review evaluates the evidence supporting an LDL-C target of less than 100 mg/dL for moderately high-risk individuals and reviews those risk factors that when present help identify patients who would benefit from achieving this lower LDL-C goal. English-language publications in MEDLINE and references from relevant articles published between January 1, 1980, and November 30, 2008, were reviewed. Main keywords searched were coronary artery disease, hyperlipidemia, statins, cardiac risk factors, inflammatory markers, metabolic syndrome, and coronary artery calcium.
ACCESSION #
37356606

 

Related Articles

  • Vascular viewpoint. Anand, Sonia S. // Vascular Medicine;2003, Vol. 8 Issue 4, p289 

    Shares views on the effect of statins on low density lipoprotein, cholesterol, ischaemic heart disease, and stroke. Determination whether how much statins can reduce serum concentrations of low density lipoprotein cholesterol according to drug, dose, and duration of treatment; Number of patients...

  • A new framework for reverse cholesterol transport: Non-biliary contributions to reverse cholesterol transport. Temel, Ryan E.; Mark Brown, J. // Annals of Gastroenterology & Hepatology;2011, Vol. 9 Issue 96, p5946 

    Reduction of low-density lipoprotein-cholesterol through statin therapy has only modestly decreased coronary heart disease (CHD)-associated mortality in developed countries, which has prompted the search for alternative therapeutic strategies for CHD. Major efforts are now focused on therapies...

  • A new framework for reverse cholesterol transport: Non-biliary contributions to reverse cholesterol transport. Temel, Ryan E.; Mark Brown, J. // Annals of Gastroenterology & Hepatology;2011, Vol. 9 Issue 93, p5946 

    Reduction of low-density lipoprotein-cholesterol through statin therapy has only modestly decreased coronary heart disease (CHD)-associated mortality in developed countries, which has prompted the search for alternative therapeutic strategies for CHD. Major efforts are now focused on therapies...

  • Intensivierte Statintherapien mit Atorvastatin sowie mit Rosuvastatin f�hren zu einem R�ckgang einer Koronarsklerose. Woitzek, Katja // Praxis (16618157);4/4/2012, Vol. 101 Issue 7, p489 

    No abstract available.

  • COMMENTARY: High-dose statins are cost-effective compared with conventional-dose statins in patients with acute coronary syndromes. Alter, David A. // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p80 

    The author reflects on the study on cost-efficacy of high-dose statin therapy over conventional-dose statins in patients with acute coronary syndromes (ACSs). He observes variation between the mechanisms of death of ACS and stable vascular disease. He also notices vagueness in the optimal target...

  • The contrOL of dYslipideMia in outPatlent clinics in GreeCe (OLYMPIC) Study. Diamantopoulos, E. J.; Athyros, V. G.; Yfanti, G. K.; Migdalis, E. N.; Elisaf, M.; Vardas, P. E.; Manolis, A. S.; Karamitsos, D. T.; Ganotakis, E. S.; Hatseras, D. // Angiology;Nov/Dec2005, Vol. 56 Issue 6, p731 

    The objective of this study was to determine the proportion of Greek patients referred to outpatient clinics for dyslipidemia who achieved the low-density lipoprotein cholesterol (LDL-C) goal defined by the National Cholesterol Education Program Adult Treatment Panel Ill (NCEP-ATP Ill)...

  • STATINS, STRESS, CORONARY DISEASE AND HYPERTENSION.  // Health & Stress;2003, Issue 9, p1 

    Reports on developments in statins. Guidelines for prescribing statins; Discovery of a class of statin medications that reduced low density lipoproteins (LDL), heart attack and death rates; Relationship of LDL to individual and population risk of coronary heart disease.

  • Atorvastatin More Effective in Reducing LDL Cholesterol. Sadovsky, Richard // American Family Physician;7/15/2002, Vol. 66 Issue 2, p325 

    Presents two abstracts of studies. 'Comparison of Efficacy and Safety of Atorvastatin and Simvastatin in Patients With Dyslipidemia With and Without Coronary Heart Disease,' by D.G. Karalis et al., from the March 15, 2002 issue of the 'American Journal of Cardiology'; 'Achieving and Maintaining...

  • Statins: Is There an Increased Risk of Diabetes? Kolich, Meghan N.; Howard, Patricia A. // Hospital Pharmacy;Jul2012, Vol. 47 Issue 7, p513 

    The article discusses the benefits of Statins, the most widely used drug class for the management of dyslipidemia. A study conducted using data from the Women's Health Initiative (WHI) and evaluated the potential for increased risk of diabetes with Statin use in postmenopausal women. The US Food...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics